Novo Nordisk's Chief Scientific Officer: The company expects to have at least five oral drug candidates in clinical development by the end of this year.

2026-09-21

Novo Nordisk's Chief Scientific Officer: The company expects to have at least five oral drug candidates in clinical development by the end of this year.